did fda ban semaglutide Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Trade group opposes Novo Nordisk's

These products have increasingly cut into the market share of brand-name manufacturers Novo Nordisk and Eli Lilly

Here's What Experts Say GLP-1 medications mimic the hormone GLP-1 to regulate blood sugar and appetite, offering benefits for weight management and type 2 diabetes treatment

This has increased the demand for products that support gut health and improve digestion during treatment

However, in this analysis, we observed similar treatment benefits of semaglutide for all primary and confirmatory secondary endpoints across the spectrum of obesity categories

We invite you to consult with our experienced healthcare professionals to explore these treatment options and how they can fit into your health and wellness goals